Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients
BackgroundIncreasing evidence shows that alterations in gut microbiome (GM) contribute to the development of type 2 diabetes mellitus (T2DM), and fecal microbiota transplantation (FMT) successfully treats various human diseases. However, the benefits of FMT therapy to T2DM patients remain unknown.Me...
Main Authors: | Dafa Ding, Huijuan Yong, Na You, Wei Lu, Xu Yang, Xiaolong Ye, Yayun Wang, Tingting Cai, Xiaoling Zheng, Hui Chen, Bota Cui, Faming Zhang, Xingyin Liu, Jian-Hua Mao, Yibing Lu, Hang Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.820367/full |
Similar Items
-
Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation
by: Margaux Marclay, et al.
Published: (2022-06-01) -
Microbiome Responses to Fecal Microbiota Transplantation in Cats with Chronic Digestive Issues
by: Connie A. Rojas, et al.
Published: (2023-09-01) -
Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study
by: Kenta Tanaka, et al.
Published: (2023-02-01) -
Prospective fecal microbiomic biomarkers for chronic wasting disease
by: Adam Didier, et al.
Published: (2024-03-01) -
The altered TBI fecal microbiome is stable and functionally distinct
by: Richard B. Pyles, et al.
Published: (2024-03-01)